Clinical Trial Update: Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial testing intensity-modulated radiation therapy (IMRT) for rectal cancer was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Rectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-02-15